Vaginal Health Screening
For your patients with chronic candidiasis, bacterial vaginosis, aerobic vaginitis, or other vaginal infections, antibiotics and antifungals may not be necessary for every occurence.
With a single swab test, LifeBrite Labs’ genomic DNA (gDNA) test gives you comprehensive insights into each patient’s vaginal microbiome. Our reports then flag for you both good and bad bacteria that are overgrown and undergrown, so you can determine when patients may benefit from a probiotic or other prophylactic treatment instead of an antibiotic or antifungal.
For many women, vaginal infections may be recurrent or become chronic, raising concerns about antibiotic resistance and disruption of a healthy vaginal microbiome. LifeBrite understands antibiotics and antifungals may not be necessary for every occurrence, and in some cases a physician may consider prescribing probiotics or other alternative treatments, either to treat an existing infection or to prevent future infections.
Milder cases of bacterial vaginosis and vulvovaginal candidiasis may even resolve without treatment, although untreated infections can lead to more serious complications. These include an increased risk of STIs including HIV in sexually active women, and premature birth and other perinatal complications in pregnant women.
LifeBrite Laboratories’ Vaginal Health Testing Includes:
Bacterial Vaginosis Panel
Aerobic Vaginitis Panel
Group B Strep Panel
Vulvovaginal Candidiasis Panel